Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: National Medical Care grand jury probe

This article was originally published in The Gray Sheet

Executive Summary

National Medical Care grand jury probe: U.S. Attorney General for the District of New Jersey will not pursue prosecution of possible criminal law violations regarding National Medical Care's efforts to convince FDA to lift a 1991 import ban of dialysis devices from the firm's Dublin, Ireland facility, the W.R. Grace unit announces. In February, the company received word that the New Jersey grand jury, which continues to investigate NMC's sale of allegedly defective products and handling of customer complaints, was considering action against NMC for violating federal rules prohibiting firms from making false submissions to the government ("The Gray Sheet" Feb. 19, I&W-14). The firm also is the target of a Virginia grand jury involving contractual relationships between NMC subsidiaries and service providers and an HHS probe regarding possible reimbursement violations...
UsernamePublicRestriction

Register

MT006237

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel